Chemomab Therapeutics Ltd... (CMMB)
NASDAQ: CMMB
· Real-Time Price · USD
2.60
0.00 (0.00%)
At close: Sep 24, 2025, 3:59 PM
2.59
-0.38%
Pre-market: Sep 25, 2025, 08:00 AM EDT
0.00% (1D)
| Bid | 2.55 |
| Market Cap | 3.01M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -11.83M |
| EPS (ttm) | -2 |
| PE Ratio (ttm) | -1.3 |
| Forward PE | -16.25 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 2.68 |
| Volume | 326,376 |
| Avg. Volume (20D) | 72,666 |
| Open | 2.61 |
| Previous Close | 2.60 |
| Day's Range | 2.55 - 2.75 |
| 52-Week Range | 2.39 - 9.84 |
| Beta | 0.55 |
| Ex-Dividend Date | n/a |
About CMMB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CMMB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CMMB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-6.27%
CMMB stock has given up its prior gain. Chemomab T...
Unlock content with
Pro Subscription
1 month ago
-6.27%
Chemomab Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results.
